CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

Zeitschrift für Herz Thorax und Gefäßchirurgie, published by Springer Heidelberg, serves as a prominent platform for disseminating vital research in the fields of cardiology, cardiovascular medicine, pulmonary and respiratory medicine, and surgery. With its ISSN 0930-9225 and E-ISSN 1435-1277, this journal not only captures significant clinical advancements but also engages with emerging trends, promoting collaboration among researchers and healthcare professionals in Germany and beyond. Although categorized in Q4 quartile across its listed specialties and holding relatively low Scopus ranks, its enduring commitment to advancing surgical methodologies and cardiovascular treatments for over two decades (from 1997 to 2024) underscores its role in the academic community. This journal is essential for those looking to stay informed about contemporary studies and innovations in heart, thoracic, and vascular surgeries.

Medicina Intensiva is a distinguished journal published by Elsevier España SLU, specializing in the critical care and intensive medicine fields. Since its inception in 1988, this peer-reviewed journal has established itself as a vital resource for healthcare professionals and researchers dedicated to advancing the knowledge and treatment of critically ill patients. With an impact factor ranked in the Q2 category for Critical Care and Intensive Care Medicine, the journal sits at the 50th percentile among its peers, reflecting its reputable standing in the academic community. The scope of the journal encompasses a wide array of topics, from clinical practices to innovative research findings, contributing significantly to the enhancement of patient care in intensive settings. Although the journal does not currently offer Open Access options, its valuable content is accessible to subscribers and institutions, reinforcing its role as an important conduit for disseminating high-quality research. As we continue into 2024, *Medicina Intensiva* remains committed to supporting the medical community through insightful articles and timely reviews that shape the future of intensive care.

ANNALS OF THORACIC SURGERY, published by Elsevier Science Inc, is a premier journal that has been serving the fields of cardiology, pulmonary medicine, and surgery since its inception in 1965. With an esteemed Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in Pulmonary and Respiratory Medicine for 2023, this journal is recognized for its rigorous peer-reviewed articles that contribute significantly to advancing surgical practices and outcomes. The journal boasts impressive Scopus rankings, placing it in the 93rd percentile for Surgery and ensuring it remains a key resource for professionals, researchers, and students. While primarily a subscription-based publication, it provides invaluable insights and original research that drive innovation and improve patient care. For those involved in thoracic surgery, this journal is indispensable, offering a platform for critical developments and collaborative discourse in the field.

The Scandinavian Journal of Trauma Resuscitation & Emergency Medicine, published by BMC, stands as a leading open-access platform dedicated to advancing the fields of trauma, resuscitation, and emergency medicine since its inception in 2008. With an ISSN of 1757-7241 and an impressive track record, this journal has established itself in the top quartile of critical care and emergency medicine, achieving Q1 rankings in both categories for 2023. Its Scopus rankings further underscore its importance, placing it among the top 11 journals in emergency medicine and the 23rd in critical care and intensive care medicine, signaling a strong impact within the academic community. As we converge toward 2024, the journal continues to provide researchers, clinicians, and students with valuable access to cutting-edge research and developments in the sector, contributing significantly to knowledge, practice, and policy in emergency care. Located in the heart of the United Kingdom, the journal remains dedicated to its mission of fostering innovation and dissemination of high-quality research, ensuring that vital medical advancements reach those who need them most.

Critical Care and Resuscitation is a premier peer-reviewed journal published by Elsevier, focusing on the dynamic fields of Anesthesiology, Critical Care, and Emergency Medicine. Established in Australia, this journal has been a significant contributor to scholarly research since its inception in 1999, maintaining a strong reputation with a commendable impact factor, evidenced by its Q1 quartile rankings across its relevant categories for 2023. The journal's commitment to disseminating high-quality research is reflected in its elite standings: it ranks #7 out of 109 in Emergency Medicine, #12 out of 136 in Anesthesiology, and #16 out of 110 in Critical Care. Aimed at researchers, clinicians, and healthcare professionals, Critical Care and Resuscitation provides a vital platform for the latest advancements in patient care and clinical strategies, making it an essential resource for those eager to stay at the forefront of these critical disciplines. Although lacking Open Access options, its rigorous peer-review process ensures the publication of valuable insights that shape current practices and influence future developments in healthcare.

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

JOURNAL OF HEART AND LUNG TRANSPLANTATION, published by Elsevier Science Inc., serves as a premier platform for researchers and clinicians in the fields of Cardiology, Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, and Transplantation. Since its inception in 1991, this esteemed journal has maintained a robust impact within the scientific community, currently holding a remarkable Q1 ranking in multiple categories as of 2023, indicative of its influential contributions to the field. With Scopus rankings placing it among the top ten in Surgery and fourth in Transplantation, it is essential reading for those looking to stay at the forefront of innovative transplantation techniques and cardiovascular research. Although not an open access journal, its rich content is crucial for advancing knowledge and promoting best practices, making it indispensable for professionals, students, and researchers dedicated to the life-saving field of heart and lung transplantation. The journal continues to foster academic excellence and facilitate impactful research, addressing contemporary challenges and innovations within these critical areas.

Heart Failure Clinics, published by Elsevier Science Inc, stands at the forefront of research and clinical practice in the rapidly evolving field of cardiology and cardiovascular medicine. With an ISSN of 1551-7136, this prestigious journal has established a reputation for high-quality peer-reviewed articles, offering critical insights into heart failure management, innovative therapies, and health care strategies. Ranked in the Q2 quartile for cardiology and cardiovascular medicine and recognized in the Q1 quartile for miscellaneous medicine as of 2023, it reflects a significant impact on both clinical and academic communities, holding a commendable position in the 73rd percentile of its category according to Scopus rankings. Since its inception in 2005, this journal has continuously been a vital resource for researchers, healthcare professionals, and students aiming to enhance their understanding of heart failure. Although it does not offer full open access options, the depth and relevance of its content make it indispensable for anyone engaged in heart health research and practice. Located in the heart of New York, at 230 Park Ave, STE 800, it aims to foster knowledge exchange and promote advancements in cardiovascular care until its converged years in 2024.

The European Journal of Heart Failure, published by Wiley, is a premier international journal dedicated to advancing the field of cardiology, specifically focusing on heart failure research and clinical practices. With an impressive impact factor and ranked in the top 1% of journals in Cardiology and Cardiovascular Medicine according to Scopus rankings (Rank #7/387, Percentile 98th), this journal serves as a vital resource for researchers, clinicians, and students alike. Spanning from 1999 to 2024, the journal has established itself as a cornerstone for innovative research, comprehensive reviews, and clinical insights, fostering a deeper understanding of heart failure mechanisms, management, and treatment strategies. Although not an open-access journal, the European Journal of Heart Failure remains committed to disseminating high-quality, peer-reviewed content that contributes significantly to the global cardiovascular community. Located in the United States at 111 River St, Hoboken, NJ 07030-5774, it continues to play an essential role in shaping the future of heart failure management.